IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CVM

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents6.531.896.2810.951.791.924.614.740.385.313.244.155.1410.0518.0222.6728.0734.2837.1136.06
Short-term Investments------------------------------0.000.000.000.006.15
Accounts Receivable------------------------------0.000.000.000.050.05
Inventory--------------1.02----2.352.25------2.00------2.01
Total Current Assets7.502.897.0311.602.623.025.866.063.548.516.156.927.7312.5720.4025.4430.9637.2841.8745.27
Property, Plant & Equipment4.585.075.576.086.587.087.598.138.619.119.6410.1910.6711.1811.5211.8912.3912.8713.2913.66
Intangible Assets0.070.070.100.120.130.140.150.170.170.180.190.200.180.190.200.210.22--0.25--
Total Non-current Assets*13.8514.8115.8616.5617.7118.7819.8420.9420.5321.5422.5623.6124.5925.6224.1525.0925.9326.8927.8030.60
Total Assets21.3617.7122.8928.1620.3421.8125.7026.9924.0730.0528.7130.5332.3238.2044.5650.5256.8964.1669.6775.87
Accounts Payable1.020.931.031.061.581.702.001.451.371.021.142.011.741.891.601.620.851.321.191.68
Total Current Liabilities5.084.815.045.135.625.505.484.625.515.094.875.595.295.314.744.664.024.473.333.94
Long-term Debt------5.68--------------------------------
Total Non-current Liabilities*5.326.026.727.077.708.318.919.5110.0910.6611.1911.7312.2412.7413.2213.7014.1514.5614.9915.40
Total Liabilities10.4010.8311.7612.2013.3113.8114.3914.1215.6015.7416.0617.3117.5318.0517.9718.3618.1619.0318.3219.34
Retained Earnings(556.03)(550.36)(544.89)(539.42)(533.32)(527.66)(521.08)(514.01)(507.90)(501.05)(493.80)(487.09)(479.46)(471.09)(462.75)(454.90)(446.44)(436.80)(426.98)(418.20)
Total Stockholder Equity10.966.8711.1415.967.028.0011.3112.878.4714.3012.6513.2114.7920.1526.5932.1638.7345.1351.3556.53
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Research & Development3.653.773.683.703.744.014.434.484.704.634.355.275.736.085.396.466.296.526.085.29
Selling, General & Admin1.911.561.692.331.752.382.461.641.972.452.132.202.452.092.262.492.433.032.763.18
Total Operating Expenses5.565.335.376.035.496.396.896.126.677.086.497.478.188.187.658.958.729.558.848.47
Operating Income(5.56)(5.33)(5.37)(6.03)(5.49)(6.39)(6.89)(6.12)(6.67)(7.08)(6.49)(7.47)(8.18)(8.18)(7.65)(8.95)(8.72)(9.55)(8.84)(8.47)
Interest Expense0.110.120.09----------------------------------
Pretax Income----------------------------------------
Net Income(5.67)(5.47)(5.47)(6.10)(5.66)(6.57)(7.07)(6.77)(6.86)(7.24)(6.71)(7.63)(8.37)(8.34)(7.85)(8.46)(9.63)(9.82)(8.78)(8.20)
Basic EPS----------------------------(0.18)(0.21)(0.23)--(0.20)(0.19)
Diluted EPS(0.47)(0.67)(0.68)(4.72)(1.36)(0.08)(0.11)3.95------------(0.18)(0.21)(0.23)(0.23)(0.20)(0.19)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow(4.03)(4.02)(4.02)(4.67)(3.94)(4.37)(4.14)(4.82)(4.58)(4.53)(4.89)(5.04)(5.67)(7.47)(4.67)(4.91)(5.79)(2.73)(4.81)(4.80)
Capital Expenditures0.000.000.000.010.000.000.030.020.020.000.050.000.200.110.050.020.070.530.020.39
Free Cash Flow*(4.03)(4.02)(4.02)(4.68)(3.94)(4.37)(4.17)(4.84)(4.60)(4.53)(4.94)(5.04)(5.86)(7.58)(4.72)(4.93)(5.86)(3.27)(4.82)(5.19)
Investing Cash Flow0.000.000.00(0.01)0.000.00(0.03)(0.02)(0.02)0.00(0.06)(0.01)(0.20)(0.11)(0.05)(0.02)(0.07)(0.53)6.114.59
Financing Cash Flow8.67(0.36)(0.65)13.843.811.684.059.19(0.32)6.604.054.070.95(0.39)0.07(0.47)(0.35)0.44(0.26)0.31
← Scroll for more columns →

* Derived from reported values